iTeos Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK, INC. | 05/02/2025 | 4.51 M | $26.92 M | 18.62% | 10.43% |
RA CAPITAL MANAGEMENT, L.P. | 05/15/2025 | 3.65 M | $21.78 M | 74.41% | 8.44% |
BVF INC/IL | 05/15/2025 | 3.08 M | $18.36 M | 32.26% | 7.11% |
MPM ASSET MANAGEMENT LLC | 05/15/2025 | 2.74 M | $16.35 B | 0.00% | 6.33% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.69 M | $16.05 M | 1,112.90% | 6.22% |
JPMORGAN CHASE & CO | 05/12/2025 | 1.98 M | $11.84 M | -4.16% | 4.59% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 1.75 M | $10.45 M | 90.61% | 4.05% |
BIOIMPACT CAPITAL LLC | 05/15/2025 | 1.75 M | $10.42 M | 0.00% | 4.04% |
VANGUARD GROUP INC | 05/09/2025 | 1.73 M | $10.31 M | 5.66% | 3.99% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 1.18 M | $7.05 M | -2.38% | 2.73% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.18 M | $7.04 M | -17.63% | 2.73% |
VESTAL POINT CAPITAL, LP | 05/15/2025 | 900.00 K | $5.37 M | 0.00% | 2.08% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 650.05 K | $3.88 M | 0.80% | 1.50% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 645.60 K | $3.85 M | -22.89% | 1.49% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 587.42 K | $3.51 M | -19.59% | 1.36% |
STATE STREET CORP | 05/15/2025 | 582.00 K | $3.47 M | -0.67% | 1.35% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 557.94 K | $3.33 M | -39.50% | 1.29% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 536.79 K | $3.20 M | 14.17% | 1.24% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 518.40 K | $3.09 M | -31.83% | 1.20% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 348.36 K | $2.08 M | -15.26% | 0.81% |
05/12/2025 | 303.65 K | $1.81 M | 100.00% | 0.70% | |
ALMITAS CAPITAL LLC | 05/15/2025 | 275.12 K | $1.64 B | 0.00% | 0.64% |
MORGAN STANLEY | 05/15/2025 | 251.13 K | $1.50 M | 0.21% | 0.58% |
NORTHERN TRUST CORP | 05/13/2025 | 250.13 K | $1.49 M | -3.70% | 0.58% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 233.56 K | $1.39 M | 17.25% | 0.54% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 226.21 K | $1.35 M | 88.59% | 0.52% |
EVERSEPT PARTNERS, LP | 05/15/2025 | 220.20 K | $1.31 M | 0.00% | 0.51% |
DAFNA CAPITAL MANAGEMENT LLC | 05/15/2025 | 213.35 K | $1.27 M | 13.27% | 0.49% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 197.90 K | $1.18 M | -3.55% | 0.46% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 188.50 K | $1.13 M | 4.74% | 0.44% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 180.10 K | $1.08 M | 193.66% | 0.42% |
KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 154.72 K | $923.66 K | 11.64% | 0.36% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 154.49 K | $922.32 K | -69.70% | 0.36% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 142.90 K | $853.11 K | -86.68% | 0.33% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 140.12 K | $836.51 K | 27.00% | 0.32% |
04/30/2025 | 135.66 K | $809.86 K | 24.62% | 0.31% | |
BARCLAYS PLC | 05/15/2025 | 128.98 K | $770.00 K | -2.95% | 0.30% |
K2 PRINCIPAL FUND, L.P. | 05/15/2025 | 120.50 K | $719.39 K | -34.69% | 0.28% |
MARSHALL WACE, LLP | 05/15/2025 | 119.56 K | $713.76 K | 100.00% | 0.28% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 05/15/2025 | 112.09 K | $669.19 K | 80.28% | 0.26% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 110.00 K | $656.70 K | 0.00% | 0.25% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 107.76 K | $643.35 K | -44.72% | 0.25% |
D. E. SHAW & CO., INC. | 05/15/2025 | 104.13 K | $621.63 K | 84.18% | 0.24% |
VICTORY CAPITAL MANAGEMENT INC | 05/02/2025 | 102.19 K | $610.06 K | 0.42% | 0.24% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 101.10 K | $603.54 K | -23.18% | 0.23% |
INVESCO LTD. | 05/12/2025 | 85.20 K | $508.66 K | 0.90% | 0.20% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 05/14/2025 | 84.50 K | $504.48 K | 100.00% | 0.20% |
ALGERT GLOBAL LLC | 05/13/2025 | 79.95 K | $477.00 K | 15.02% | 0.18% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 78.59 K | $469.15 K | 0.00% | 0.18% |
HSBC HOLDINGS PLC | 05/14/2025 | 76.99 K | $458.49 K | 62.41% | 0.18% |
iTeos Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 166 institutional investors and hedge funds held shares of iTeos Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 4.51 M
RA CAPITAL MANAGEMENT, L.P.: 3.65 M
BVF INC/IL: 3.08 M
MPM ASSET MANAGEMENT LLC: 2.74 M
TANG CAPITAL MANAGEMENT LLC: 2.69 M
JPMORGAN CHASE & CO: 1.98 M
85.49% of iTeos Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 43.89 M shares in the last 24 months. This purchase volume represents approximately $446.34 M in transactions.